PL3490533T3 - Sposób stabilizacji rozmiaru cząstek - Google Patents

Sposób stabilizacji rozmiaru cząstek

Info

Publication number
PL3490533T3
PL3490533T3 PL17751294T PL17751294T PL3490533T3 PL 3490533 T3 PL3490533 T3 PL 3490533T3 PL 17751294 T PL17751294 T PL 17751294T PL 17751294 T PL17751294 T PL 17751294T PL 3490533 T3 PL3490533 T3 PL 3490533T3
Authority
PL
Poland
Prior art keywords
particle size
stabilization process
size stabilization
particle
stabilization
Prior art date
Application number
PL17751294T
Other languages
English (en)
Inventor
Josep TERRADAS CAMINS
Josep María CARULLA OLIVER
Silvia DONNICI GARCÍA
David GÓMEZ LAMARCA
María José MARTÍNEZ VELÓN
Emma RECIO SOLER
Original Assignee
Inke, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inke, S.A. filed Critical Inke, S.A.
Publication of PL3490533T3 publication Critical patent/PL3490533T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/02—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL17751294T 2016-07-29 2017-07-25 Sposób stabilizacji rozmiaru cząstek PL3490533T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16382374 2016-07-29
PCT/EP2017/068707 WO2018019803A1 (en) 2016-07-29 2017-07-25 Particle size stabilization process
EP17751294.4A EP3490533B1 (en) 2016-07-29 2017-07-25 Particle size stabilization process

Publications (1)

Publication Number Publication Date
PL3490533T3 true PL3490533T3 (pl) 2020-11-02

Family

ID=56842772

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17751294T PL3490533T3 (pl) 2016-07-29 2017-07-25 Sposób stabilizacji rozmiaru cząstek

Country Status (7)

Country Link
US (1) US10888500B2 (pl)
EP (1) EP3490533B1 (pl)
AR (1) AR109186A1 (pl)
ES (1) ES2805434T3 (pl)
PL (1) PL3490533T3 (pl)
PT (1) PT3490533T (pl)
WO (1) WO2018019803A1 (pl)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2956062A (en) 1959-02-26 1960-10-11 Robins Co Inc A H Esters of amino alcohols
GB0409703D0 (en) 2004-04-30 2004-06-02 Vectura Ltd Pharmaceutical compositions
KR20100065270A (ko) 2007-07-10 2010-06-16 어드밴스드 트랜스포트 시스템즈 리미티드 자동의 차량 유도 보호 시스템
US20100247658A1 (en) 2007-12-13 2010-09-30 Gerhard Muhrer Organic compounds
WO2009074666A1 (en) 2007-12-13 2009-06-18 Novartis Ag Organic compounds
JP6454323B2 (ja) 2013-03-15 2019-01-16 パール セラピューティクス,インコーポレイテッド 粒子状結晶性材料のコンディショニングのための方法及びシステム
US9393202B2 (en) * 2013-04-26 2016-07-19 Chiesi Farmaceutici S.P.A Particle size reduction of an antimuscarinic compound
US10131630B2 (en) 2014-12-24 2018-11-20 Laboratorios Lesvi, S.L. Process for preparing (3RS)-3-[(2SR)-(2-cyclopentyl-2-hydroxy-2-phenylacetyl)oxy]-1,1-dimethylpyrrolidinium bromide

Also Published As

Publication number Publication date
AR109186A1 (es) 2018-11-07
US20190175451A1 (en) 2019-06-13
ES2805434T3 (es) 2021-02-12
EP3490533A1 (en) 2019-06-05
US10888500B2 (en) 2021-01-12
WO2018019803A1 (en) 2018-02-01
PT3490533T (pt) 2020-07-21
EP3490533B1 (en) 2020-05-27

Similar Documents

Publication Publication Date Title
IL277137B (en) Stable suspensions of nanomagnetic particles
IL246989A0 (en) A controlled process to reduce particle size
GB201609546D0 (en) Process
PL3265271T3 (pl) Podajnik cząstek
GB201615268D0 (en) Process
GB201605121D0 (en) Process
GB201609873D0 (en) Process
PL3096866T3 (pl) Drobnoziarnisty węgiel aktywowany
GB201615270D0 (en) Process
GB201600290D0 (en) Process
GB201618121D0 (en) Process
GB201701573D0 (en) Virus-like particle
GB201602584D0 (en) Process
GB201615762D0 (en) Process
GB201617500D0 (en) Process
GB201617463D0 (en) Process
GB201600287D0 (en) Process
GB201620667D0 (en) Process
GB201602646D0 (en) Process
GB201600456D0 (en) Process
GB201620655D0 (en) Methanaol process
GB201613014D0 (en) Process
GB201517478D0 (en) Particle surface treatment
PT3548452T (pt) Partícula de fertilizante
GB201604608D0 (en) Process